Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|March 14, 2022
Cost of cancer management by stage at diagnosis among Medicare beneficiariesSheila R Reddy, Michael S Broder, Eunice Chang, et al.
BMC Cancer|July 22, 2024
Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature reviewKaren C Chung, Anushini Muthutantri, Grace G Goldsmith, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 14, 2021
Health state utility values by cancer stage: a systematic literature reviewMir-Masoud Pourrahmat, Ashley Kim, Anuraag R Kansal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2012
Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastasesLouis S Matza, Lesley J Fallowfield, Karen C Chung, et al.
Leukemia & Lymphoma|April 10, 2020
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapyJoseph Tkacz, Jacob Garcia, Mathew Gitlin, et al.
The Patient|July 17, 2022
Patient Preferences for Multi-Cancer Early Detection (MCED) Screening TestsHeather Gelhorn, Melissa M Ross, Anuraag R Kansal, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Journal of Medical Economics|February 19, 2019
Health state utilities associated with treatment options for acute myeloid leukemia (AML)Louis S Matza, Kristen A Deger, Timothy A Howell, et al.
Pageof 3